Journal of the National Cancer Institute Advance Access originally published online on April 7, 2009
JNCI Journal of the National Cancer Institute 2009 101(8):610; doi:10.1093/jnci/djp042
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2009. Published by Oxford University Press.
CORRESPONDENCE |
Re: The Influence of Statin Medications on Prostate-Specific Antigen Levels
Affiliations of authors: Internal Medicine, Aging and Kidney Disease Department, University of Bologna, Bologna, Italy (AFGC, AVG); Internal Medicine and Therapeutics Department, University of Pavia, Pavia, Italy (GD)
Correspondence to: Arrigo F. G. Cicero, MD, PhD, "G. Descovich" Atherosclerosis Research Centre, Internal Medicine, Aging and Kidney Diseases Department, S. Orsola-Malpighi Hospital, Via Massarenti 9—Pad. 22, 40138 Bologna, Italy (e-mail: afgcicero@cardionet.it).
| The first 10% of the full text of this article appears below. |
In a recent article in the Journal (1), Hamilton et al. provided further evidence of the possible role of statins in modulating prostate-specific antigen (PSA) plasma levels. As clinical